
EniacPharma provides AI-driven antibodies for personalized treatment. The platform uses droplet microfluidics and AI to identify antibodies that target specific cells. This is a B2B biotech platform serving research labs and pharmaceutical partners, integrating with common research workflows and data systems. The approach aims to accelerate discovery and development of antibody therapies at scale for the biotech and pharma markets.

EniacPharma provides AI-driven antibodies for personalized treatment. The platform uses droplet microfluidics and AI to identify antibodies that target specific cells. This is a B2B biotech platform serving research labs and pharmaceutical partners, integrating with common research workflows and data systems. The approach aims to accelerate discovery and development of antibody therapies at scale for the biotech and pharma markets.